日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Immunological mechanisms and antibody-drug conjugates targeting B7-H3 and B7-H4 in ovarian cancer

卵巢癌中针对B7-H3和B7-H4的免疫机制和抗体药物偶联物

Brown, Emily Frances; Colombo, Ilaria; Madariaga, Ainhoa; Kasherman, Lawrence

What services are available for culturally and linguistically diverse (CALD) patients in the cancer survivorship setting? An Australian study

癌症康复机构中,有哪些服务可供文化和语言背景多元化(CALD)的患者使用?一项澳大利亚研究

Kasherman, Lawrence; Addo, Isaac Yeboah; Tan, Sim Yee Cindy; Malalasekera, Ashanya; Shaw, Joanne; Vardy, Janette

Copper chelation redirects neutrophil function to enhance anti-GD2 antibody therapy in neuroblastoma

铜螯合可改变中性粒细胞功能,从而增强抗GD2抗体在神经母细胞瘤中的疗效

Jourdin R C Rouaen ,Antonietta Salerno ,Tyler Shai-Hee ,Jayne E Murray ,Giulia Castrogiovanni ,Charlotte McHenry ,Toni Rose Jue ,Vu Pham ,Jessica Lilian Bell ,Ensieh Poursani ,Emanuele Valli ,Riccardo Cazzoli ,Naomi Damstra ,Delia J Nelson ,Kofi L P Stevens ,Jonathan Chee ,Iveta Slapetova ,Maria Kasherman ,Renee Whan ,Francis Lin ,Blake J Cochran ,Nicodemus Tedla ,Feyza Colakoglu Veli ,Aysen Yuksel ,Chelsea Mayoh ,Federica Saletta ,Daniele Mercatelli ,Tatyana Chtanova ,Arutha Kulasinghe ,Daniel Catchpoole ,Giuseppe Cirillo ,Maté Biro ,Holger N Lode ,Fabio Luciani ,Michelle Haber ,Juliet C Gray ,Toby N Trahair ,Orazio Vittorio

Cancer survivorship programs for patients from culturally and linguistically diverse (CALD) backgrounds: a scoping review

针对来自文化和语言背景多元化(CALD)患者的癌症生存计划:范围界定综述

Kasherman, Lawrence; Yoon, Won-Hee; Tan, Sim Yee Cindy; Malalasekera, Ashanya; Shaw, Joanne; Vardy, Janette

Immune checkpoint inhibitors in ovarian cancer: where do we go from here?

卵巢癌免疫检查点抑制剂:我们下一步该怎么做?

Yoon, Won-Hee; DeFazio, Anna; Kasherman, Lawrence

Hydrocephalus in Nfix(-/-) Mice Is Underpinned by Changes in Ependymal Cell Physiology.

Nfix(-/-) 小鼠的脑积水是由室管膜细胞生理变化引起的

Harkins Danyon, Harvey Tracey J, Atterton Cooper, Miller Ingrid, Currey Laura, Oishi Sabrina, Kasherman Maria, Davila Raul Ayala, Harris Lucy, Green Kathryn, Piper Hannah, Parton Robert G, Thor Stefan, Cooper Helen M, Piper Michael

Angiogenesis Inhibitors and Immunomodulation in Renal Cell Cancers: The Past, Present, and Future

肾细胞癌中的血管生成抑制剂和免疫调节:过去、现在和未来

Kasherman, Lawrence; Siu, Derrick Ho Wai; Woodford, Rachel; Harris, Carole A

Angiogenesis: A Pivotal Therapeutic Target in the Drug Development of Gynecologic Cancers

血管生成:妇科肿瘤药物研发中的关键治疗靶点

Kasherman, Lawrence; Liu, Shiru Lucy; Karakasis, Katherine; Lheureux, Stephanie

Comment on evolutionary dynamics of cancer multidrug resistance in response to olaparib and photodynamic therapy

评论癌症多药耐药性对奥拉帕尼和光动力疗法的进化动态反应

Madariaga, Ainhoa; Kasherman, Lawrence; McMullen, Michelle; Bonilla, Luisa

Elp2 mutations perturb the epitranscriptome and lead to a complex neurodevelopmental phenotype

Elp2 突变扰乱表观转录组并导致复杂的神经发育表型

Marija Kojic, Tomasz Gawda, Monika Gaik, Alexander Begg, Anna Salerno-Kochan, Nyoman D Kurniawan, Alun Jones, Katarzyna Drożdżyk, Anna Kościelniak, Andrzej Chramiec-Głąbik, Soroor Hediyeh-Zadeh, Maria Kasherman, Woo Jun Shim, Enakshi Sinniah, Laura A Genovesi, Rannvá K Abrahamsen, Christina D Fenger